Pharmacological management of SAPHO syndrome (Q28264660)

Expert Opinion on Investigational Drugs

Europe PubMed Central

title

Pharmacological management of SAPHO syndrome (English)

0 references

1 reference

1 reference

Ignazio Olivieri

1

0 references

Angela Padula

series ordinal

2

0 references

Carlo Palazzi

series ordinal

3

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

0 references

volume

15

0 references

issue

10

0 references

page(s)

1229-33

0 references

cites work

SAPHO syndrome treated with pamidronate: an open-label study of 10 patients

1 reference

https://api.crossref.org/works/10.1517/13543784.15.10.1229

Pamidronate in the treatment of childhood SAPHO syndrome

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.15.10.1229

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Calcitonin treatment for intersternocostoclavicular ossification: clinical experience in two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Pamidronate: a novel treatment for the SAPHO syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Pamidronate treatment in SAPHO syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Treatment of SAPHO with pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Pamidronate for SAPHO syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

SAPHO syndrome and pamidronate revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Successful treatment of SAPHO syndrome with zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Successful treatment of SAPHO syndrome with infliximab: report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome: comment on the article by Wagner et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1229

10.1517/13543784.15.10.1229

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3723611

OpenCitations bibliographic resource ID

3723611

1 reference